ammoxetine hydrochloride
/ CSPC Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 8
Of
8
Go to page
1
August 11, 2026
Evaluation of Bioequivalence and Food Effect of a New Strength Formulation of Ammoxetine Hydrochloride Enteric-coated Tablets in Healthy Participants.
(clinicaltrials.gov)
- P1 | N=62 | Recruiting | Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
New P1 trial
July 11, 2026
A Phase I Clinical Trial to Evaluate the Pharmacokinetic Characteristics of Ammoxetine Hydrochloride Enteric-Coated Tablets in Participants With Moderate Renal Impairment and Normal Renal Function
(clinicaltrials.gov)
- P1 | N=16 | Recruiting | Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
New P1 trial • Renal Disease
July 10, 2026
A Phase I Clinical Trial to Evaluate the Pharmacokinetic and Safety of Ammoxetine Hydrochloride Enteric-Coated Tablets in Participants With Mild Hepatic Impairment, Moderate Hepatic Impairment, and Normal Liver Function
(clinicaltrials.gov)
- P1 | N=24 | Recruiting | Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
New P1 trial • Hepatology • AFP
April 03, 2026
A Clinical Trial to Evaluate the Effect of Food on the Pharmacokinetics of Ammoxetine Hydrochloride Enteric-coated Tablets in Healthy Subjects
(clinicaltrials.gov)
- P1 | N=18 | Completed | Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
New P1 trial
April 03, 2026
Food-effect Study of Ammoxetine Hydrochloride Enteric-coated Tablets
(clinicaltrials.gov)
- P1 | N=14 | Completed | Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
New P1 trial
February 16, 2025
The Research of Ammoxetine Hydrochloride Enteric-coated Tablets in Subjects With Depression
(clinicaltrials.gov)
- P3 | N=770 | Not yet recruiting | Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
New P3 trial • CNS Disorders • Depression • Major Depressive Disorder • Mood Disorders • Psychiatry
March 09, 2023
The Study of Ammoxetine Hydrochloride Enteric-coated Tablets in Subjects With Depression
(clinicaltrials.gov)
- P2 | N=240 | Not yet recruiting | Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
New P2 trial • CNS Disorders • Depression • Major Depressive Disorder • Mood Disorders • Psychiatry
November 12, 2021
Study of Ammoxetine Hydrochloride Enteric-coated Tablets in Subjects With Depression
(clinicaltrials.gov)
- P2; N=240; Recruiting; Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.; Not yet recruiting ➔ Recruiting
Clinical • Enrollment open • CNS Disorders • Depression • Major Depressive Disorder • Mood Disorders • Psychiatry
1 to 8
Of
8
Go to page
1